A Novel Series of Potent and Selective PDE5 Inhibitors with Potential for High and Dose-Independent Oral Bioavailability
- 24 May 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 49 (12) , 3581-3594
Abstract
Sildenafil (5-[2-ethoxy-5-(4-methyl-1-piperazinylsulfonyl)phenyl]-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one), a potent and selective phosphodiesterase type 5 (PDE5) inhibitor, provided the first oral treatment for male erectile dysfunction. The objective of the work reported in this paper was to combine high levels of PDE5 potency and selectivity with high and dose-independent oral bioavailability, to minimize the impact on the Cmax of any interactions with coadministered drugs in the clinic. This goal was achieved through identification of a lower clearance series with a high absorption profile, by replacing the 5‘-piperazine sulfonamide in the sildenafil template with a 5‘-methyl ketone. This novel series provided compounds with low metabolism in human hepatocytes, excellent caco-2 flux, and the potential for good aqueous solubility. The in vivo oral and iv pharmacokinetic profiles of example compounds confirmed the high oral bioavailability predicted from these in vitro screens. 5-(5-Acetyl-2-butoxy-3-pyridinyl)-3-ethyl-2-(1-ethyl-3-azetidinyl)-2,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one (2) was selected for progression into the clinic.Keywords
This publication has 8 references indexed in Scilit:
- Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and manXenobiotica, 1999
- Crystallography & NMR System: A New Software Suite for Macromolecular Structure DeterminationActa Crystallographica Section D Structural Biology, 1998
- Synthesis of functionalized 3‐pyridyl methyl ketonesJournal of Heterocyclic Chemistry, 1998
- [21] Data collection strategy1997
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settingsAdvanced Drug Delivery Reviews, 1997
- The use of the intestinal epithelial cell culture model, Caco-2, in pharmaceutical developmentAdvanced Drug Delivery Reviews, 1996
- The CCP4 suite: programs for protein crystallographyActa Crystallographica Section D Structural Biology, 1994
- Catalytic Hydration of Alkylacetylenes1Journal of the American Chemical Society, 1938